This research study is looking at biomarkers in DNA samples from patients with acute lymphoblastic leukemia or acute myeloid leukemia. Studying samples of DNA from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Differences in induction outcome, dichotomized into complete remission or no remission
Timeframe: Up to 8 years
Differences in induction outcome, dichotomized into complete remission or no remission
Timeframe: Up to 8 years
Differences in overall survival
Timeframe: Up to 8 years
Disease-free survival (DFS)
Timeframe: Time from the end of induction to relapse or death, assessed up to 8 years
Relapse-free survival
Timeframe: Time from the end of induction to marrow relapse or death from progressive disease, censoring on deaths from other causes, assessed up to 8 years
Etiology of leukemia: Chi square test
Timeframe: Up to 8 years
Etiology of leukemia: Fisher's exact test
Timeframe: Up to 8 years